151 related articles for article (PubMed ID: 37900421)
1. Clinical and Immunological Impacts of Latent Toxoplasmosis on COVID-19 Patients.
Habib S; Hamza E; El-Gamal R; Nosser NA; Aboukamar WA; Abdelsalam S; Sobh A; Elegezy M; Elbayoumy M; Eldars W; Elmasry K; Elnagdy MH
Cureus; 2023 Sep; 15(9):e45989. PubMed ID: 37900421
[TBL] [Abstract][Full Text] [Related]
2. Effect of SARS-CoV-2 and Toxoplasma gondii co-infection on IFN-γ and TNF-α expression and its impact on disease severity.
Abdeltawab MSA; Fateen M; Saad El-Din S; Elmessiery RM; Mohammady Mohamed O; Marzouk Sadek K; Medhat E; Hamed AMR
Cytokine; 2024 May; 177():156545. PubMed ID: 38368695
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Association Between Latent Toxoplasma gondii Infection and COVID-19 in Hospitalized Patients: First Registry-Based Study.
Montazeri M; Nakhaei M; Fakhar M; Pazoki H; Pagheh AS; Nazar E; Zakariaei Z; Mirzaeian H; Sharifpour A; Banimostafavi ES; Musavi F; Rasouli K; Soleymani M; Moradi E
Acta Parasitol; 2022 Sep; 67(3):1172-1179. PubMed ID: 35545737
[TBL] [Abstract][Full Text] [Related]
4. Toxoplasmosis and symptoms severity in patients with COVID-19 in referral centers in Northern Iran.
Geraili A; Badirzadeh A; Sadeghi M; Mousavi SM; Mousavi P; Shahmoradi Z; Hosseini SM; Hejazi SH; Rafiei-Sefiddashti R
J Parasit Dis; 2023 Mar; 47(1):185-191. PubMed ID: 36532601
[TBL] [Abstract][Full Text] [Related]
5. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
Deckert-Schlüter M
Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
[TBL] [Abstract][Full Text] [Related]
6. Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells.
Dzitko K; Grzybowski MM; Pawełczyk J; Dziadek B; Gatkowska J; Stączek P; Długońska H
Parasit Vectors; 2015 Aug; 8():422. PubMed ID: 26272689
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of Toxoplasma gondii Infection Among Β-Thalassemia Major Pediatric Population: Implications for Transfusion Transmissible Toxoplasmosis.
El-Tantawy N; Darwish A; Eissa E
Pediatr Infect Dis J; 2019 Mar; 38(3):236-240. PubMed ID: 29762364
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Specific Cellular and Humoral Immune Response to
Andrade CMR; de Lima Marques AC; Timóteo RP; de Morais Oliveira-Scussel AC; De Vito FB; da Silva MV; Mineo JR; Teodoro RB; Rodrigues DBR; Júnior VR
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979909
[TBL] [Abstract][Full Text] [Related]
9. Toxoplasmosis impact on prematurity and low birth weight.
Hurt K; Kodym P; Stejskal D; Zikan M; Mojhova M; Rakovic J
PLoS One; 2022; 17(1):e0262593. PubMed ID: 35025961
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of
Esenkaya Taşbent F; Beder D; Özdemir M; Doğan M; Feyzioğlu B
Turkiye Parazitol Derg; 2022 Mar; 46(1):1-6. PubMed ID: 35232698
[TBL] [Abstract][Full Text] [Related]
11. Toxoplasma gondii infection in Kyrgyzstan: seroprevalence, risk factor analysis, and estimate of congenital and AIDS-related toxoplasmosis.
Minbaeva G; Schweiger A; Bodosheva A; Kuttubaev O; Hehl AB; Tanner I; Ziadinov I; Torgerson PR; Deplazes P
PLoS Negl Trop Dis; 2013; 7(2):e2043. PubMed ID: 23409201
[TBL] [Abstract][Full Text] [Related]
12. Cerebral and ocular toxoplasmosis related with IFN-γ, TNF-α, and IL-10 levels.
Meira CS; Pereira-Chioccola VL; Vidal JE; de Mattos CC; Motoie G; Costa-Silva TA; Gava R; Frederico FB; de Mattos LC;
Front Microbiol; 2014; 5():492. PubMed ID: 25352834
[TBL] [Abstract][Full Text] [Related]
13. Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in nonhuman immunodeficiency virus-infected subjects with no lymphadenopathy: the parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches.
Prandota J
Am J Ther; 2007; 14(1):63-105. PubMed ID: 17303977
[TBL] [Abstract][Full Text] [Related]
14. Detection of immunoglobulin G antibodies to Toxoplasma gondii: Evaluation of two commercial immunoassay systems.
Tekkesin N; Keskin K; Kılınc C; Orgen N; Molo K
J Microbiol Immunol Infect; 2011 Feb; 44(1):21-6. PubMed ID: 21531348
[TBL] [Abstract][Full Text] [Related]
15. IgG4 specific to Toxoplasma gondii excretory/secretory antigens in serum and/or cerebrospinal fluid support the cerebral toxoplasmosis diagnosis in HIV-infected patients.
Meira CS; Vidal JE; Costa-Silva TA; Motoie G; Gava R; Hiramoto RM; Pereira-Chioccola VL
J Immunol Methods; 2013 Sep; 395(1-2):21-8. PubMed ID: 23811152
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictors of Toxoplasma gondii infection in pregnant women from Dhamar, Yemen.
Al-Adhroey AH; Mehrass AAO; Al-Shammakh AA; Ali AD; Akabat MYM; Al-Mekhlafi HM
BMC Infect Dis; 2019 Dec; 19(1):1089. PubMed ID: 31888517
[TBL] [Abstract][Full Text] [Related]
17. [Problems and limitations of conventional and innovative methods for the diagnosis of Toxoplasmosis in humans and animals].
Piergili Fioretti D
Parassitologia; 2004 Jun; 46(1-2):177-81. PubMed ID: 15305712
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Seropositivity of Toxoplasmosis Suspected Patients Admitted to the National Parasitology Reference Laboratory Between 2009 and 2019.
Babür C; Yücesan B; Sezen F; Kılıç S
Turkiye Parazitol Derg; 2021 Aug; 45(3):181-189. PubMed ID: 34346873
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serological markers for the immunodiagnosis of acute acquired toxoplasmosis.
Suzuki LA; Rocha RJ; Rossi CL
J Med Microbiol; 2001 Jan; 50(1):62-70. PubMed ID: 11192507
[TBL] [Abstract][Full Text] [Related]
20. Particularly neglected in countries with other challenges: High Toxoplasma gondii seroprevalence in pregnant women in Kabul, Afghanistan, while a low proportion know about the parasite.
Mosawi SH; Zarghona Z; Dalimi A; Jokelainen P; Safa AH; Mohammadi MR; Javanmardi E; Basirat MB
PLoS One; 2019; 14(10):e0223585. PubMed ID: 31600338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
